Citalopram Rapid Test Panel (Urine) (Urine), Drug Abuse CIT Test Kit. Detection Of Desmethylcitalopram
| Product Name: |
Citalopram Rapid Test Panel (Urine) (Urine), Drug Abuse CIT Test Kit. Detection Of Desmethylcitalopram |
| Brand: |
Citest |
| Format: |
Panel |
| Certificate: |
CE |
| Pack: |
25/40T/50T |
| Shelf Life: |
2 Years |
| Specificity: |
95.50% |
| Cut-Off: |
500 Ng/mL |
| CAT NO.: |
DCIT-114 |
| Principle: |
Chromatographic Immunoassay |
| Specimen: |
Urine |
| Reading Time: |
5 Minutes |
| Storage Temperature: |
2-30°C |
| Sensitivity: |
93.30% |
| Accuracy: |
94.80% |
| PRODUCT FEATURES: |
Multiple Formats Available |
Citalopram Rapid Test Panel (Urine) (Urine), Drug Abuse CIT Test Kit. detection of Desmethylcitalopram
INTENDED USE
The CIT Rapid Test Panel (Urine) is a rapid chromatographic immunoassay for the detection of Desmethylcitalopram in urine at a cut-off concentration of 500ng/ml. This test will detect other related compounds, please refer to the Analytical Specificity table in this package insert.
This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
PRINCIPLE
The CIT Rapid Test Panel (Urine) is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody. During testing, a urine specimen migrates upward by capillary action. Desmethylcitalopram, if present in the urine specimen below the cut-off level, will not saturate the binding sites of the antibody in the test. The antibody coated particles will then be captured by immobilized Citalopram-protein conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the Desmethylcitalopram level exceeds the cut-off level, because it will saturate all the binding sites of anti-citalopram antibody. A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration less than the cut-off will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.
PRECAUTIONS
- For professional in vitro diagnostic use only.
- Do not use after the expiration date.
- The test should remain in the sealed pouch until use.
- All specimens should be considered potentially hazardous and handled in the same manner as an infectious agent.
- The used test should be discarded according to local regulations.
DIRECTIONS FOR USE
Allow the test, urine specimen, and/or controls to reach room temperature (15-30°C)
prior to testing.
1. Remove the test panel from the sealed pouch and use it as soon as possible.
2. Remove the cap.
3. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the strip to at least the level of the wavy lines, but do not touch the plastic device.
4. Replace the cap and place the test panel on a non-absorbent flat surface.
5. Start the timer and wait for the colored line(s) to appear.
6. The drug strip result should be read at 5 minutes. Do not interpret the result after 10 minutes.
QUALITY CONTROL
A procedural control is included in the test. A colored line appearing in the control line region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique. Control standards are not supplied with this kit; however, it is recommended that positive and negative controls be tested as good laboratory testing practice to confirm the test procedure
and to verify proper test performance.
